Use and Outcomes of Noninvasive Positive Pressure Ventilation in Acute Care Hospitals in Massachusetts

dc.contributor.authorUgurlu, Aylin Ozsancak
dc.contributor.authorSidhom, Samy S.
dc.contributor.authorKhodabandeh, Ali
dc.contributor.authorIeong, Michael
dc.contributor.authorMohr, Chester
dc.contributor.authorLin, Denis Y.
dc.contributor.authorBuchwald, Irwin
dc.contributor.authorBahhady, Imad
dc.contributor.authorWengryn, John
dc.contributor.authorMaheshwari, Vinay
dc.contributor.orcIDhttps://orcid.org/0000-0003-3598-3986en_US
dc.contributor.pubmedID24480997en_US
dc.contributor.researcherIDAAA-2925-2020en_US
dc.date.accessioned2024-02-22T13:37:22Z
dc.date.available2024-02-22T13:37:22Z
dc.date.issued2014
dc.description.abstractBackground: This study determined actual utilization rates and outcomes of noninvasive positive pressure ventilation (NIV) at selected hospitals that had participated in a prior survey on NIV use. Methods: This observational cohort study, based at eight acute care hospitals in Massachusetts, focused on all adult patients requiring ventilatory support for acute respiratory failure during predetermined time intervals. Results: Of 548 ventilator starts, 337 (61.5%) were for invasive mechanical ventilation and 211 (38.5%) were for NIV, with an overall NIV success rate of 73.9% (ie, avoidance of intubation or death while on NIV or within 48 h of discontinuation). Causal diagnoses for respiratory failure were classifi ed as (I) acute-on-chronic lung disease (23.5%), (II) acute de novo respiratory failure (17.9%), (III) neurologic disorders (19%), (IV) cardiogenic pulmonary edema (16.8%), (V) cardiopulmonary arrest (12.2%), and (VI) others (10.6%). NIV use and success rates for each of the causal diagnoses were, respectively, (I) 76.7% and 75.8%, (II) 37.8% and 62.2%, (III) 1.9% and 100%, (IV) 68.5% and 79.4%, (V) none, and (VI) 17.2% and 60%. Hospital mortality rate was higher in patients with invasive mechanical ventilation than in patients with NIV (30.3% vs 16.6%, P < .001). Conclusions: NIV occupies an important role in the management of acute respiratory failure in acute care hospitals in selected US hospitals and is being used for a large majority of patients with acute-on-chronic respiratory failure and acute cardiogenic pulmonary edema. NIV use appears to have increased substantially in selected US hospitals over the past decade.en_US
dc.identifier.endpage971en_US
dc.identifier.issn0012-3692en_US
dc.identifier.issue5en_US
dc.identifier.scopus2-s2.0-84899798552en_US
dc.identifier.startpage964en_US
dc.identifier.urihttp://hdl.handle.net/11727/11578
dc.identifier.volume145en_US
dc.identifier.wos000336532100012en_US
dc.language.isoengen_US
dc.relation.isversionof10.1378/chest.13-1707en_US
dc.relation.journalCHESTen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergien_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectACUTE RESPIRATORY-FAILUREen_US
dc.subjectMECHANICAL VENTILATIONen_US
dc.subjectEXACERBATIONSen_US
dc.titleUse and Outcomes of Noninvasive Positive Pressure Ventilation in Acute Care Hospitals in Massachusettsen_US
dc.typeArticleen_US

Files

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: